Re-inventing tumor targeting
Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.
Latest news
Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001
Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001
Thermosome announces the appointment of Dr. Sabine Hauck as Chief Technology Officer (CTO)
ASCO Annual Meeting
May 30–June 3, 2025
Chicago, USA
